Psychological distress in patients with morphea and eosinophilic fasciitis

Archives of Dermatology

Volumn 145, Issue 9, 2009, Pages 1017-1022

  Kroft, Elisabeth B M ^a   De Jong, Elke M G J ^a   Evers, Andrea W M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ANXIETY DISORDER; ARTICLE; CHILD; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEPRESSION; DISEASE SEVERITY; DISTRESS SYNDROME; EOSINOPHILIC FASCIITIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORPHEA; OUTPATIENT DEPARTMENT; PHYSICIAN; PRIORITY JOURNAL; PSYCHOLOGIC TEST; QUESTIONNAIRE; SCHOOL CHILD; SCLEROSIS; SELF REPORT; SOCIAL PSYCHOLOGY; SOCIAL SUPPORT; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

ACTIVITIES OF DAILY LIVING; ADULT; CROSS-SECTIONAL STUDIES; EOSINOPHILIA; FASCIITIS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NETHERLANDS; PREVALENCE; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS; SCLERODERMA, LOCALIZED; SEVERITY OF ILLNESS INDEX; STRESS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 70349316852     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2009.202     Document Type: Article

References (23)

1. Bertken R, Shaller D. Chronic progressive eosinophilic fasciitis: report of a 20-year failure to attain remission. Ann Rheum Dis. 1983;42(1):103-105. (Pubitemid 13148349)
2. Tuffanelli DL. Localized scleroderma. Semin Cutan Med Surg. 1998;17(1):27-33.
3. Varga J, Griffin R, Newman JH, Jimenez SA. Eosinophilic fasciitis is clinically distinguishable from the eosinophilia-myalgia syndrome and is not associated with L-tryptophan use. J Rheumatol. 1991;18(2):259-263.
4. Evers AW, Lu Y, Duller P, van der Valk PG, Kraaimaat FW, van de Kerkhof PC. Common burden of chronic skin diseases? contributors to psychological distress in adults with psoriasis and atopic dermatitis. Br J Dermatol. 2005;152(6):1275-1281. (Pubitemid 40933429)
5. Steptoe A, Kimbell J, Basford P. Exercise and the experience and appraisal of daily stressors: a naturalistic study. J Behav Med. 1998;21(4):363-374. (Pubitemid 28447445)
6. Verhoeven EW, Kraaimaat FW, van de Kerkhof PC, et al. Prevalence of physical symptoms of itch, pain and fatigue in patients with skin diseases in general practice. Br J Dermatol. 2007;156(6):1346-1349.
7. Evers AW, Kraaimaat FW, van Lankveld W, Jongen PJ, Jacobs JW, Bijlsma JW. Beyond unfavorable thinking: the illness cognition questionnaire for chronic diseases. J Consult Clin Psychol. 2001;69(6):1026-1036.
8. Cohen S, Wills TA. Stress, social support, and the buffering hypothesis. Psychol Bull. 1985;98(2):310-357.
9. Wills TA, Filer M. Social network and the buffering hypothesis. In: Baum A, Revenson TA, Singer JE, eds. Handbook of Health Psychology. London, England: Lawrence Erlbaum; 2001:209-234.
10. Evers AW, Duller P, van de Kerkhof PC, et al. The Impact of Chronic Skin Disease on Daily Life (ISDL): a generic and dermatology-specific health instrument. Br J Dermatol. 2008;158(1):101-108. (Pubitemid 350225551)
11. Evers AW, Taal E, Kraaimaat FW, et al. A comparison of two recently developed health status instruments for patients with arthritis: Dutch-AIMS2 and IRGL. Br J Rheumatol. 1998;37(2):157-164. (Pubitemid 28375184)
12. van der Ploeg HM, Defares PB, Spielberger CD. Manual to the ZelfBeoordelingsVragenlijst [in Dutch]. 2nd ed. Lisse, the Netherlands: Swets & Zeitlinger; 2000.
13. Zwart F, Spooren J. Development of a Self-Report Questionnaire for Depression [in Dutch]. Utrecht, the Netherlands: University Medical Center Utrecht; 1982.
14. Fortune DG, Richards HL, Griffiths CE, Main CJ. Psychological stress, distress and disability in patients with psoriasis: consensus and variation in the contribution of illness perceptions, coping and alexithymia. Br J Clin Psychol. 2002;41(pt 2):157-174.
15. Perrott SB, Murray AH, Lowe J, Mathieson CM. The psychosocial impact of psoriasis: physical severity, quality of life, and stigmatisation. Physiol Behav. 2000;70(5):567-571. (Pubitemid 30953018)
16. Richards HL, Fortune DG, Griffiths CE, Main CJ. The contribution of perceptions of stigmatisation to disability in patients with psoriasis. J Psychosom Res. 2001;50(1):11-15.
17. Scharloo M, Kaptein AA, Weinman J, Bergman W, Vermeer BJ, Rooijmans HG. Patients' illness perceptions and coping as predictors of functional status in psoriasis: a 1-year follow-up. Br J Dermatol. 2000;142(5):899-907. (Pubitemid 30304599)
18. de Korte J, Sprangers MA, Mombers FM, Bos JD. Quality of life in patients with psoriasis: a systematic literature review. J Investig Dermatol Symp Proc. 2004;9(2):140-147. (Pubitemid 38457272)
19. Stangier U, Ehlers A. Stress and anxiety in dermatological disorders. In: Mostofsky DI, Barlow DH, eds. The Management of Stress and Anxiety in Medical Disorders. Needham Heights, MA: Allyn & Bacon; 2000:304-343.
20. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210-216.
21. Huiskes CJAE, Kraaimaat FW, Bijlsma JWJ. Development of a self-report questionnaire to assess the impact of rheumatic disease on health and lifestyle. J Rehabil Sci. 1990;3:65-70.
22. Chren MM, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ. Skindex, a quality of life measure for patients with skin disease: reliability, validity and responsiveness. J Invest Dermatol. 1996;107(5):707-713.
23. Fortune DG, Richards HL, Kirby B, Bowcock S, Main CJ, Griffiths CE. A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy. Br J Dermatol. 2002;146(3):458-465. (Pubitemid 34603818)